Amia Capital LLP Sage Therapeutics, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$58.41 - $89.06 $446,486 - $680,774	-7,644 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $18,385 - $27,915	447 Added 6.21%	7,644 $467,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $102,813 - $170,960	-3,962 Reduced 35.5%	7,197 $299,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $75,364 - $222,605	-2,882 Reduced 20.53%	11,159 $320,000
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $844,987 - $2.17 Million	14,041 New	14,041 $1.01 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.